Charles N. Ellis

15.9k total citations
235 papers, 11.6k citations indexed

About

Charles N. Ellis is a scholar working on Dermatology, Immunology and Molecular Biology. According to data from OpenAlex, Charles N. Ellis has authored 235 papers receiving a total of 11.6k indexed citations (citations by other indexed papers that have themselves been cited), including 112 papers in Dermatology, 84 papers in Immunology and 43 papers in Molecular Biology. Recurrent topics in Charles N. Ellis's work include Psoriasis: Treatment and Pathogenesis (72 papers), Dermatology and Skin Diseases (68 papers) and Retinoids in leukemia and cellular processes (36 papers). Charles N. Ellis is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (72 papers), Dermatology and Skin Diseases (68 papers) and Retinoids in leukemia and cellular processes (36 papers). Charles N. Ellis collaborates with scholars based in United States, Canada and Germany. Charles N. Ellis's co-authors include John J. Voorhees, Aditya K. Gupta, Gerald G. Krueger, Richard G. Langley, Nicholas J. Schork, C.E.M. Griffiths, Gerald G. Krueger, Kevin D. Cooper, Ted Hamilton and Michael Goldfarb and has published in prestigious journals such as New England Journal of Medicine, JAMA and Journal of Clinical Investigation.

In The Last Decade

Charles N. Ellis

232 papers receiving 10.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Charles N. Ellis United States 58 5.9k 4.4k 1.9k 1.5k 1.4k 235 11.6k
Yoshiki Miyachi Japan 65 5.0k 0.8× 4.6k 1.0× 3.8k 2.0× 1.1k 0.7× 1.7k 1.2× 506 15.9k
Jan D. Bos Netherlands 50 4.4k 0.7× 4.4k 1.0× 710 0.4× 829 0.5× 1.1k 0.8× 131 9.3k
P.C.M. van de Kerkhof Netherlands 61 8.0k 1.4× 8.9k 2.0× 1.6k 0.9× 2.0k 1.3× 1.8k 1.3× 498 15.9k
Wolf‐­Henning Boehncke Germany 55 4.4k 0.7× 8.7k 2.0× 2.1k 1.1× 1.3k 0.8× 2.7k 1.9× 356 13.2k
Thomas Schwarz Germany 57 4.7k 0.8× 4.5k 1.0× 2.2k 1.2× 681 0.4× 426 0.3× 204 10.6k
John Koo United States 55 6.8k 1.2× 8.0k 1.8× 966 0.5× 1.4k 0.9× 1.7k 1.2× 339 12.5k
Ulrich Mrowietz Germany 60 5.9k 1.0× 7.5k 1.7× 1.9k 1.0× 1.5k 1.0× 1.4k 0.9× 331 12.7k
Peter Fritsch Austria 51 2.0k 0.3× 4.1k 0.9× 2.1k 1.1× 787 0.5× 729 0.5× 246 9.9k
Nicholas A. Soter United States 47 2.6k 0.4× 2.6k 0.6× 897 0.5× 1.0k 0.7× 2.3k 1.6× 168 8.2k
Akimichi Morita Japan 50 3.8k 0.6× 4.5k 1.0× 1.1k 0.6× 892 0.6× 889 0.6× 355 8.5k

Countries citing papers authored by Charles N. Ellis

Since Specialization
Citations

This map shows the geographic impact of Charles N. Ellis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles N. Ellis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles N. Ellis more than expected).

Fields of papers citing papers by Charles N. Ellis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles N. Ellis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles N. Ellis. The network helps show where Charles N. Ellis may publish in the future.

Co-authorship network of co-authors of Charles N. Ellis

This figure shows the co-authorship network connecting the top 25 collaborators of Charles N. Ellis. A scholar is included among the top collaborators of Charles N. Ellis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles N. Ellis. Charles N. Ellis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ellis, Charles N., et al.. (2017). Improving patient satisfaction in dermatology: a prospective study of an urban dermatology clinic.. PubMed. 99(4). 273–278. 2 indexed citations
3.
4.
Ellis, Charles N., et al.. (2009). Evaluating the severity of dermatologic disorders. Dermatologic Therapy. 22(3). 191–198. 5 indexed citations
5.
Ellis, Charles N. & Thomas A. Luger. (2003). International consensus conference on atopic dermatitis II (ICCAD II) Clinical update & current treatment strategies. British Journal of Dermatology. 148(63). 1–10. 6 indexed citations
6.
Ellis, Charles N. & TA Luger. (2003). International Consensus Conference on Atopic Dermatitis II (ICCAD II): Chairman's Introduction and Overview. British Journal of Dermatology. 148(s63). 1–2. 10 indexed citations
7.
Ellis, Charles N., L A Drake, Mary M. Prendergast, et al.. (2001). Third-party payer cost of atopic dermatitis and eczema in the United States. Journal of Investigative Dermatology. 117(2). 531. 1 indexed citations
8.
Nyirady, Judit, Wilma F. Bergfeld, Charles N. Ellis, et al.. (2001). Tretinoin cream 0.02% for the treatment of photodamaged facial skin: a review of 2 double-blind clinical studies.. PubMed. 68(2). 135–42. 24 indexed citations
9.
Kaplan, Mariana J., et al.. (1999). Systemic Toxicity Following Administration of Sirolimus (Formerly Rapamycin) for Psoriasis. Archives of Dermatology. 135(5). 553–7. 39 indexed citations
10.
Bata‐Csörgõ, Zsuzsanna, et al.. (1997). Rapamycin (sirolimus) inhibits proliferating cell nuclear antigen expression and blocks cell cycle in the G1 phase in human keratinocyte stem cells.. Journal of Clinical Investigation. 99(9). 2094–2099. 62 indexed citations
11.
Young, Eric W., Charles N. Ellis, Joseph M. Messana, et al.. (1994). A prospective study of renal structure and function in psoriasis patients treated with cyclosporin. Kidney International. 46(4). 1216–1222. 62 indexed citations
12.
Rafal, Elyse S., C.E.M. Griffiths, Chérie M. Ditre, et al.. (1992). Topical Tretinoin (Retinoic Acid) Treatment for Liver Spots Associated with Photodamage. New England Journal of Medicine. 326(6). 368–374. 114 indexed citations
13.
Berman, Brian, Charles N. Ellis, William D. James, et al.. (1992). Efficacy of a 1-week, twice-daily regimen of terbinafine 1 % cream in the treatment of interdigital tinea pedis. Journal of the American Academy of Dermatology. 26(6). 956–960. 55 indexed citations
14.
Gupta, Aditya K., Marc D. Brown, Charles N. Ellis, et al.. (1989). Cyclosporine in dermatology. Journal of the American Academy of Dermatology. 21(6). 1245–1256. 74 indexed citations
15.
Solomon, Alvin R., et al.. (1989). Malignant Dermal Cylindroma in a Patient with Multiple Dermal Cylindromas, Trichoepitheliomas, and Bilateral Dermal Analogue Tumors of the Parotid Gland. American Journal of Dermatopathology. 11(4). 353–359. 26 indexed citations
16.
Ellis, Charles N., et al.. (1988). Long-term radiographic follow-up after isotretinoin therapy. Journal of the American Academy of Dermatology. 18(6). 1252–1261. 24 indexed citations
17.
Chalker, Dan K., Jack L. Lesher, Jason G. Smith, et al.. (1987). Efficacy of topical isotretinoin 0.05% gel in acne vulgaris: Results of a multicenter, double-blind investigation. Journal of the American Academy of Dermatology. 17(2). 251–254. 56 indexed citations
18.
Ellis, Charles N., et al.. (1985). Radiographic bone surveys after isotretinoin therapy for cystic acne. Acta Dermato Venereologica. 65(1). 83–85. 7 indexed citations
19.
Ellis, Charles N., Roy C. Grekin, & Neil A. Swanson. (1981). Serum lipid changes during aromatic retinoid (RO 10-9359) therapy for psoriasis. Journal of Investigative Dermatology. 76(4). 2 indexed citations
20.
Julius, Stevo, Murray Esler, & Charles N. Ellis. (1976). The nervous system in arterial hypertension : [proceedings]. Thomas eBooks. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yoshiki Miyachi Breakdown of academic impact, for papers by Jan D. Bos Breakdown of academic impact, for papers by P.C.M. van de Kerkhof Breakdown of academic impact, for papers by Wolf‐­Henning Boehncke Breakdown of academic impact, for papers by Thomas Schwarz Breakdown of academic impact, for papers by John Koo Breakdown of academic impact, for papers by Ulrich Mrowietz Breakdown of academic impact, for papers by Peter Fritsch Breakdown of academic impact, for papers by Nicholas A. Soter Breakdown of academic impact, for papers by Akimichi Morita
Rankless by CCL
2026